Bing

Recently announced, medical device major Boston Scientific Corporation (BSX - Analyst Report ... s target of $50 million in revenues from DBS therapy by 2017. Currently, the stock carries a Zacks Rank #3 (Hold). The company’s peers such as Medtronic ...
ZACKS · 6/18/2013
Novavax, Inc. (NVAX) of the Healthcare sector is down -0.32% (change from open 0.98%) this morning trading at a volume of 1,027,678 shares and price of $6.18. Novavax, Inc. (NVAX)’s weekly performance is 4.20% and compared to their 52 week low …
wallstreetscope.com · 1/16/2015
Shares closed trading on Friday at $9.58. Boston Scientific Corp. (NYSE: BSX) had a director emeritus at the medical devices company buying stock this past week. That director purchased a block of 100,000 shares of the stock at prices that ranged from …
24/7 Wall ST · 8/22/2015
Insider Buying
The stock’s 50 day moving average is $75.99 and its 200-day moving ... Medtronic’s ICD peers include St. Jude Medical (NYSE:STJ) and Boston Scientific (NYSE:BSX). The Company offers its products to doctors …
jewocity.com · 1 day ago
Trading at a sub-1.0 PEG with a dividend yield near 1.5%, there are plenty of reasons for value and income-seeking investors to like this stock. Boston Scientific (NYSE:BSX) sits at No. 3 on our list, and 8% of the hedge funds we track are bullish.
Seeking Alpha · 2/14/2013
Following is Zimmer (NYSE:ZMH) with EBITDA growth of 206.7%. Finishing up the top three is Boston Scientific (NYSE:BSX), with EBITDA growth of 161.4%. Home Properties's stock is up 0.1% to $74.40 on heavy trading volume. Today's volume o
Financial News Network Online · ByMallory Stone · 8/14/2015
It didn't have any relevance to where we or the market were heading," said Michael Cox, chairman of NSX, which acquired the Bendigo Stock Exchange, or BSX, in 2005. New clients wanted a national profile and trading platform for their stock but perceived ...
Wall Street Journal · 6/18/2012
The Bermuda Stock Exchange (BSX) has issued a lengthy defense of its primary position as the “domicile of choice” for insurance linked securities (ILS); pointing out that 57 percent of such securities issued in 2014 were handled on the island ...
Insurance Journal · 1/28/2015
There's no foolproof way to know the future for Boston Scientific (NYSE: BSX ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. A cloudy crystal ball In this ...
The Motley Fool · BySeth Jayson · 1/3/2013
Perry Ellis Int'l (NASDAQ: PERY) 14.8% LOWER; expects total Q4 revenue to be approximately $218 million, versus the consensus of $242.4 million and EPS of $0.01 to $0.04 versus the consensus of $0.43. Enphase Energy (NASDAQ: ENPH) 14.1% …
StreetInsider · 2/17/2015

Boston Scientific

The Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used …
The Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Data from: Wikipedia · Freebase